Publications by authors named "Aktolkyn Rustemova"
Article Synopsis
- Oral semaglutide is the first oral glucagon-like peptide-1 receptor agonist, effectively managing blood sugar levels and weight in individuals with type 2 diabetes.
- The study administered oral semaglutide to mice following human protocols, revealing significant reductions in blood glucose levels and food intake, especially at higher doses.
- The findings indicate that these mice are an appropriate model for further research into the drug's mechanisms for managing obesity and diabetes.
